Kester Capital
9
2M
8
0.60
6
0.11
3
- Areas of investment
Summary
Kester Capital appeared to be the VC, which was created in 2007. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the London.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Kester Capital, startups are often financed by The Still River Fund, HealthCare Ventures, Yasuda Enterprise Development. The meaningful sponsors for the fund in investment in the same round are Yasuda Enterprise Development, The Still River Fund, Neomed Management. In the next rounds fund is usually obtained by GTCR, Fosun Group.
Among the most popular portfolio startups of the fund, we may highlight Xanthus Pharmaceuticals. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Association. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Besides them, we counted 4 critical employees of this fund in our database.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2006. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 66 percentage points more often commits exit comparing to other organizations. This Kester Capital works on 28 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2008.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 6
- Exits
- 3
- Rounds per year
- 0.60
- Follow on index
- 0.11
- Investments by industry
- Medical Device (3)
- Pharmaceutical (2)
- Biopharma (2)
- Health Care (2)
- Software (2) Show 6 more
- Investments by region
-
- United States (2)
- Netherlands (1)
- United Kingdom (5)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 0.11
- Avg. company exit year
- 19
- Avg. multiplicator
- 0.48
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Xanthus Pharmaceuticals | 01 Dec 2006 | Biotechnology, Medical, Pharmaceutical, Biopharma | Early Stage Venture | 25M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.